Sinonasal Oncocytic Papilloma—A Series of 20 Cases With Special Emphasis on Recurrences by Lilja, Markus et al.

Laryngoscope Investigative Otolaryngology
© The Authors. Laryngoscope Investigative Otolaryngology
published by Wiley Periodicals, Inc. on behalf of The Triological Society.
Sinonasal Oncocytic Papilloma—A Series of 20 Cases With Special
Emphasis on Recurrences
Markus Lilja, MD, PhD†; Sanna Viitasalo, MD†; Maija Hytönen, MD, PhD ; Aaro Haapaniemi, MD, PhD ;
Jaana Hagström, DDS, PhD; Antti Mäkitie, MD, PhD
Objective: Reports on sinonasal oncocytic papilloma (SNOP) are scarce. The aim of this retrospective study was to evalu-
ate the clinical features of this rarest form of sinonasal papilloma with special emphasis on the pattern of recurrences and on
the potential factors predicting them.
Study Design: Retrospective study.
Methods: Between the years 1994 and 2016, 20 patients (mean age 66 years; range 30–87) were diagnosed with SNOP
at the Department of Otorhinolaryngology–Head and Neck Surgery, HUS Helsinki University Hospital (Helsinki, Finland). Hospi-
tal charts were reviewed to record various medical and sociodemographic patient characteristics, and the archived histological
specimens were re-evaluated. Postoperative follow-up time varied between 26 days and 167 months.
Results: Maxillary sinus was the most common (60%) tumor location. None of the tissue samples showed dysplasia.
Recurrence rate was 39% and the median time span to the ﬁrst recurrence was 25 months (range 7–71). Smokers had more
often a recurrence than nonsmokers (75% vs. 31%). Patients with perioperative purulent rhinosinusitis during the primary
surgery had a higher recurrence rate compared with those without (60% vs. 31%). Tumors located in the sinuses recurred
more often than those located in the nasal cavity (45% vs. 29%). However, all these ﬁndings remained statistically nonsigniﬁ-
cant. None of the cases showed malignant transformation during the follow-up.
Conclusion: SNOP has a propensity to recur. History of smoking, purulent rhinosinusitis during the primary surgery, and
tumor location in the sinuses outside the nasal cavity seem to contribute to an increased trend in the risk of recurrence.
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INTRODUCTION
A great variety of both benign and malignant neo-
plasms may occur in the sinonasal tract.1 Sinonasal papillo-
mas form a clinically important group for differential
diagnostics. They arise from the ectodermally derived cili-
ated columnar, respiratory epithelium (Schneiderian mem-
brane) lining nasal cavity, and paranasal sinuses, and are
therefore also called as Schneiderian papillomas.2 Sinonasal
papillomas are rare tumors, with an overall annual inci-
dence of 0.74 cases per 100,000 people.3 They are divided
into three subtypes according to their morphology. The ter-
minology has previously been variable but the latest version
(4th edition) of the WHO Classiﬁcation of Head and Neck
Tumours applies the names sinonasal exophytic papilloma
(SNEP), sinonasal inverted papilloma (SNIP), and sinonasal
oncocytic papilloma (SNOP).1 The proportions of these three
sinonasal papilloma subtypes vary in the existing reports
but SNOP remains themost uncommon. AnAmerican study
by Hyams on 315 cases reported 50% SNEPs (fungiform),
47% SNIPs, and 3% SNOPs.4 In a Canadian series of
72 cases, the percentages were 18%, 76%, and 5.5%,
respectively,5 and in a Danish series of 82 patients, 23%,
70%, and 6%, respectively.3
Due to the rarity of SNOP, the literature is also scarce
and mostly consists of case reports. Typically these patients
are presented as part of a larger series of sinonasal papillo-
mas.2,3,6 Only one previous study (n = 33) focuses onSNOPs7
and therefore, there is an obvious need for reports on this
rare histological subtype.
The aim of this retrospective study was to evaluate
the clinical features of this rarest form of sinonasal papil-
lomas with special emphasis on the pattern of recur-
rences and on the potential factors predicting them. In
addition, rate of dysplasia in the surgical specimens and
rate of metachronous malignancies (ie, not occurring at
the time of SNOP diagnosis) during the follow-up were
investigated.
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MATERIALS AND METHODS
This retrospective study comprised 20 patients treated with a
diagnosis of SNOP between 1994 and 2016 at the Department of
Otorhinolaryngology–Head and Neck Surgery, Helsinki University
Hospital (Helsinki, Finland). The SNOP diagnosis was available
from the year 1994 onward in the data register of Department of
Pathology. Hospital charts were reviewed to record various patient,
disease, diagnostic method, treatment, and postoperative follow-up
parameters. As there is no established ofﬁcial SNOP classiﬁcation
available, all cases were classiﬁed according to the Krouse staging
system for SNIP (Table I). Classiﬁcation was made based on endo-
scopic, radiological, and perioperative ﬁndings. One patient (#4) had
no preoperative imaging available and his lesion was classiﬁed
according to the perioperative ﬁndings only. Seven (35%) patients
were diagnosed with perioperative purulent rhinosinusitis and
microbiological samples were taken. The factors potentially
impacting the recurrence ratewere analyzed by using SPSSVersion
22 (SPSS, Inc., Chicago, IL, http://www-01.ibm.com/software/uk/
analytics/spss/, https://www.ibm.com, RRID:SCR_002865). The chi-
square test was used for evaluation of differences between groups.
Two-sided P value was calculated using either Pearson chi-square
test or Fisher’s exact test depending on the respective study setting.
An institutional study permissionwas granted for the study.
RESULTS
Classiﬁcation, Diagnosis, and Treatment
There were altogether 20 SNOP patients and the basic
characteristics of this study population are presented in
Table II. Nine (45%) of the patients were female and
11 (55%) were male. Four (20%) patients were current
smokers. All tumors were unilateral and the side of the dis-
ease was nearly equally distributed. Maxillary sinus was
the most usual location (60%). Seven (35%) patients had
perioperative purulent rhinosinusitis during the primary
surgery. All six available bacterial samples were positive.
Fungal samples were available for three patients. One
patient had a positive fungal culture and another had a posi-
tive ﬁnding in the fungal swab sample. One of the microbio-
logical reports was not available for review. Preoperative
computed tomography was performed in 95% of the cases.
Magnetic resonance imaging was used in the diagnostics of
one patient. One patient (patient #4) with tumor location
only in the nasal septum was not imaged preoperatively.
Endoscopic technique was used in 55% of the cases, and in
one of them in combination with open surgery (patient #19).
This patient had tumor inmaxillary sinus and a partly endo-
scopically assisted Caldwell-Luc procedure was performed.
The nine cases with open surgery consisted of four Caldwell-
Luc approaches, four external medial maxillectomies, one
frontal sinus osteoplastic ﬂap approach, and one removal of
the septal tumor. First endoscopic surgery was done in 2005
and this technique was then used in most cases (9/12, 75%).
TABLE I.
Krouse Staging System for Inverted Papilloma.8
Type 1 Tumor totally conﬁned to the nasal cavity, without extension into
the sinuses. The tumor can be localized to one wall or region
of the nasal cavity, or can be bulky and extensive within the
nasal cavity, but must not extend into the sinuses or into any
extranasal compartment. There must be no concurrent
malignancy.
Type 2 Tumor involving the ostiomeatal complex, and ethmoid sinuses,
and/or the medial portion of the maxillary sinus, with or
without involvement of the nasal cavity. There must be no
concurrent malignancy.
Type 3 Tumor involving the lateral, inferior, superior, anterior, or
posterior walls of the maxillary sinus, the sphenoid sinus,
and/or the frontal sinus, with or without involvement of the
medial portion of the maxillary sinus, the ethmoid sinuses, or
the nasal cavity. There must be no concurrent malignancy.
Type 4 All tumors with any extranasal/extrasinus extension to involve
adjacent, contiguous structures such as the orbit, the
intracranial compartment, or the pterygomaxillary space. All
tumors associated with malignancy.
TABLE II.
Characteristics Related to the Patients and Their Disease and
Treatment.
Number of Patients (%)
Sex
Female 9 (45%)
Male 11 (55%)
Smoking
Current 4 (20%)
Former 3 (15%)
Never 12 (60%)
Data missing 1 (5%)
Side of the disease
Right 11 (55%)
Left 9 (45%)
Main location
Nasal septum 1 (5%)
Nasal cavity 6 (30%)
Maxillary sinus 12 (60%)
Frontal sinus 1 (5%)
Krouse stage
Type 1 4 (20%)
Type 2 3 (15%)
Type 3 13 (65%)
Type 4 0 (0%)
Perioperative purulent rhinosinusitis
Yes 7 (35%)
No 13 (65%)
Preoperative imaging
Computed tomography 19 (95%)
Without contrast 10 (50%)
With contrast 9 (45%)
Magnetic resonance imaging 1 (5%)
Without contrast 1 (5%)
With contrast 0
Surgical technique
Open surgery 10 (50%)
Endoscopic surgery 9 (45%)
Combined 1 (5%)
Further treatment of the primary site (eg, cauterization, bone
drilling/resection)
Yes 5 (25%)
No 15 (75%)
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Five (25%) patients received further treatment for the tumor
site as follows: laser cauterization (N = 1), bone drilling
(N = 1), bone resection (N = 1), electrocauterization (N = 1),
and combination of bone resection and electrocauterization
of the surroundingmucousmembrane (N = 1).
Follow-Up
The sex and age of the patients, and their follow-up
details including data on the recurrences are shown in
Table III. The age of the patients ranged between 30 and
87 years and the mean age was 66 years. Postoperative
follow-up time varied between 26 days and 167 months.
Two patients died of other causes within 1 year after the
ﬁrst operation for SNOP. Patient #3 had chronic lympho-
cytic leukemia and he died in less than 1 month after the
operation. Patient #10 had carcinoma in his transverse
colon and he died 10 months after the operation. At the
time of data analysis, 18 patients had been followed up
for more than 24 months and they were all included in
the recurrence evaluation. For these 18 patients, the
median follow-up time was 44 months (range 24–167).
Seven (39%) patients had at least one recurrence. The
median time for the ﬁrst recurrence was 25 months
(range 7–71). Two (29%) out of the seven primary recur-
rences were found during the ﬁrst follow-up year and
three (43%) recurrences during the ﬁrst two follow-up
years. Three (43%) of the seven patients with a recurrence
had a second recurrence later during their follow-up. The
interval between the ﬁrst and the second recurrence varied
between 12 and 45 months. None of the patients had more
than two recurrences. All recurrences were found in the
same location as the primary tumor.
Possible Factors Related to the Recurrence Rate
Table IV shows the patients divided into two sub-
groups; those with a recurrence and those without. The
distribution of the different factors among these groups is
presented. Smokers had more recurrences (75%) than
nonsmokers (31%) (former smokers and never smokers
combined), but the difference did not reach statistical sig-
niﬁcance (P = .445). Recurrences were most uncommon in
cases primarily located in the nasal cavity, but this ﬁnd-
ing was not statistically signiﬁcant (P = .603). Patients
with purulent rhinosinusitis during the primary surgery
showed a higher recurrence rate than patients without,
but the difference was not statistically signiﬁcant
(P = .326). Figure 1 shows the contrast enhanced com-
puter tomography image of a 87-year-old female patient
(patient #14) with SNOP in the right maxillary sinus and
nasal cavity. Patient had an acute infection at the time of
TABLE III.
Twenty Patients With Oncocytic Papilloma.
Patient
Number
Age at
Diagnosis
Day (yr) Sex
The First
Recurrence*
The Second
Recurrence*
Interval Between
the First and
Second
Recurrence†
Follow-Up
Time*
Disease-Free
Follow-Up
Time From the Last
Surgery†
Death From
Other
Causes*
1 63 F 7.1 51.9 44.9 117.9 66
2 30 M 71.1 89.9 18.9
3 81 M 0.9 0.9 0.9
4 40 M 167 167
5 78 F 40.3 40.3
6 55 M 15.2 39.4 22.4
7 76 F 48.3 48.3
8 58 M 152 152
9 75 M 25.4 37.8 12.4 79.6 41.9
10 86 M 8.6 8.6 9.6
11 51 F 39.3 63.7 24.4 87.2 23.5
12 62 F 35.9 35.9
13 57 M 69.3 69.3
14 87 F 6.9 40.7 33.7
15 66 F 50.3 50.3
16 85 F 33.6‡ 33.6
17 63 M 35.3 35.3
18 59 F 27.6 31.2‡ 0.3
19 76 M 31.8‡ 31.8
20 69 M 24.6‡ 24.6
Data on time intervals during follow-up.
*Time in months after the ﬁrst surgery.
†Time in months.
‡Follow-up will continue.
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tumor removal, and she later had a tumor recurrence.
Patients with Krouse stage 1 or 3 had recurrences during
the follow-up (50% and 45%, respectively), but patients
with Krouse stage 2 had not (P = .421). Surgical tech-
nique and further treatment modalities to the tumor site
showed no effect on the recurrence rate.
Dysplasia and Malignancy
Altogether, there were 44 tissue samples available
for these 20 patients for histological analysis and none of
them showed dysplasia. None of the patients developed a
malignant tumor in the nasal cavity or paranasal sinuses
during the follow-up.
DISCUSSION
We report on a comprehensive series of 20 consecu-
tive SNOP cases treated at a single university hospital
during 22 years. The mean age (66 years) of our patients
corresponds to that in previous reports.2,7,9 Only two
patients were younger than 50 years of age. Nine out of
the 20 patients were female, which is in accordance with
previous literature showing that SNOP is equally distrib-
uted between the sexes.7,9
Recurrences
The recurrence rate in the present series was 39%. This
ﬁnding iswell in linewith previous reports showing recurrence
rates between 17% and 40%.2,4,6 Karligkiotis et al observed a
much lower recurrence rate of 6% in a series of 33 SNOP
patients.7 Due to the high frequency of recurrences, careful
follow-up is generally recommended.6 Some of our patients
experienced late recurrences and therefore, we currently
advise them to contact our hospital if any sinonasal symptoms
recur after the last endoscopic follow-up examination.
In the present study, we aimed at evaluating the
potential factors affecting the recurrence rate, that is,
smoking, surgical technique, tumor location, Krouse
stage, purulent rhinosinusitis during the primary sur-
gery, and further treatment for the primary site. Unfortu-
nately, the number of patients was too low to show any
statistically signiﬁcant differences.
Smoking
Three out of the four current smokers had a recur-
rence. The recurrence rate was much lower (31%) among
never and former smokers. On the other hand, only one of
the three patients with a second recurrence was a
smoker. Both previous and current smoking have been
reported to be a risk factor for recurrences in SNIP
patients and consequent increased mucosal inﬂammation
has been the suggested possible explanation.10,11 Similar
reports regarding SNOP do not exist and we only found a
trend without statistical signiﬁcance in our series.
Fig. 1. The contrast enhanced computer tomography picture of the
87-year-old female patient (#14) with sinonasal oncocytic papilloma
(asterisk) in the right maxillary sinus and nasal cavity. The middle part of
the mass showed contrast enhancement and also lamellar structures,
which raised the suspicion of sinonasal papilloma. The tumor had caused
bone remodellation at the region of ostiomeatal complex (ellipse). Peri-
operatively several pus accumulationswere found among tumormass.
TABLE IV.
Potential Factors Related to Recurrence Rate.
Patients With a
Recurrence
Patients With No
Recurrence
P
Value
Smoking
Current 3 (75%) 1 (25%)
Former 1 (33%) 2 (67%)
Never 3 (30%) 7 (70%)
Data missing 0 (0%) 1 (100%) .445
Surgical technique
Open surgery 3 (43%) 4 (57%)
Endoscopic
surgery
4 (40%) 6 (60%)
Combined 0 (0%) 1 (100%) 1.0
Main location
Nasal cavity 2 (29%) 5 (71%)
Maxillary sinus 4 (40%) 6 (60%)
Frontal sinus 1 (100%) 0 (0%) .603
Krouse stage
Type 1 2 (50%) 2 (50%)
Type 2 0 (0%) 3 (100%)
Type 3 5 (45%) 6 (55%) .421
Perioperative purulent rhinosinusitis
Yes 3 (60%) 2 (40%) .326
No 4 (31%) 9 (69%)
Further treatment of the primary site
Yes 2 (40%) 3 (60%)
No 5 (38%) 8 (62%) 1.0
Patients with at least 2 yr of follow-up were included (N = 18).
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Surgical Technique
The present study did not demonstrate a statistically
signiﬁcant difference in the recurrence rate between the
nonendoscopic surgery group and the endoscopic surgery
group. With modern video-assisted endoscopic approach, it
is possible to obtain better visibility and therefore, more
accurate removal of the tumor than with open surgery.
Majority of SN surgery is currently performed endoscopi-
cally and there is increasing evidence for endoscopic removal
of SNIP being associated with at least comparable results to
external approaches and with less morbidity.12–14 Many
authors now state that endoscopic approach may be consid-
ered the preferred technique in managing most inverted
papillomaswhile only aminority of the tumorswarrant com-
bined or external approach. In the study of Karligkiotis et al,
33 SNOP patients were successfully managed with endo-
scopic surgery.7 Only in one case with a frontal sinus lesion,
osteoplastic ﬂap technique was combined with endoscopic
technique. Asmentioned earlier, the recurrence rate was 6%
and there were no intraoperative complications, and long-
term complicationswere found in only three patients.
Tumor Location
In our series, tumor location was most often the maxil-
lary sinus (60%), followed by the nasal cavity, including the
ethmoidal area (35%), and the frontal sinus (5%). None of
the tumors was located in the sphenoid sinus. This is in
accordance with other studies reporting maxillary sinus as
the most usual site for these tumors.2,6,7 Tumors located in
the sinuses recurred more often than those located in the
nasal cavity, but the difference was not statistically signiﬁ-
cant. Complete removal of the tumors originating frommax-
illary, sphenoid, or frontal sinuses is typically more
challenging compared with those in the nasal cavity or eth-
moidal sinuses. On the other hand, there are other chal-
lenges in the resection of tumors in the ethmoidal area, that
is, those originating from lamina papyracea or skull base.
Krouse Stage
Krouse staging was primarily developed for SNIP.8 It
may also be useful for SNOP due to its similar clinical
behavior and it has been applied in one previous study con-
cerning this entity.7 In our material, the most usual Krouse
stage was type 3. There were no type 4 cases with tumor
extension to extrasinonasal spaces or association with
malignancy. We only found two reported cases in the litera-
ture with a benign SNOP extending through normal ana-
tomical borders of the nasal and paranasal cavities.15,16 The
present study showed no statistically signiﬁcant differences
in the recurrence rate between Krouse types. The recent
meta-analysis regarding SNIP patients reported higher
likelihood of recurrence inKrouse type 3.17
Perioperative Purulent Rhinosinusitis
The recurrence rate seemed to be higher among the
patients with perioperative purulent rhinosinusitis (60%)
compared with the patients without (31%). Interestingly,
the three shortest intervals between the primary surgery
and the ﬁrst recurrence were in the patient group with
purulent rhinosinusitis. Their recurrences appeared after
7–15 months postoperatively. It is possible that infection
of the tissues has made surgical radicality more challeng-
ing to be assessed perioperatively and that some of these
patients rather had residual disease than recurrences.
This ﬁnding has clinical impact and will guide the future
surgical management of patients with perioperative puru-
lent rhinosinusitis at our center. We are not aware of
other reports focusing on the coexisting infection at the
time of primary SNOP surgery.
Further Treatment for the Primary Site
Some reports highlight the importance of additional
treatment for the tumor resection site, that is, removing
totally or partly (drilling) the underlying bone.18,19 Although
currently the removing or drilling of the underlying bone of
the tumor is recommended as an essential part of adequate
primary surgery, in our retrospective material it had been
performed only in 3 out of 18 patients. In this study, we used
the term further/additional surgery as an umbrella term cov-
ering both the removing or drilling of the underlying bone of
the tumor and the cauterization (electro/laser) of tumor
attachment site. Furthermore, the recurrence rate was even
higher among these patients with additional surgery, but the
difference was not statistically signiﬁcant. However, we rec-
ognize inadequate primary surgery as one potential explana-
tion for the high recurrence rate in our study.
Dysplasia and Malignancies
SNOP and SNIP may be associated with malignan-
cies, that can be synchronous (ie, occurring at the time of
papilloma diagnosis) or metachronous (ie, not occurring
at the time of papilloma diagnosis, but found later during
the follow-up).1 None of our cases had malignant transfor-
mation during the follow-up. A total of 43 histological
samples were available for re-evaluation in this series
and none of them showed dysplasia. Thus, we could not
ﬁnd any metachronous malignancies in the current
series. The fact that we were not able to report synchro-
nous malignancies diagnosed during the same time
period is a limitation of our study. These are registered
according to a malignant diagnosis and therefore, all
sinonasal malignancies during the same time period
should be re-evaluated histologically to identify synchro-
nous cases.
According to theWHOClassiﬁcation of Head and Neck
Tumours around 4%–17% of all SNOPs harbor a carci-
noma.1 However, re-evaluation of the three references to
this claim showed that this issue warrants further consider-
ation. The ﬁrst article by Kaufman et al reports 40 patients
with SNIP and SNOP.6 Six out of the 40 patients had SNOP
and one of them had a synchronous malignancy, which was
not more speciﬁcally deﬁned. The second reference was a
case report with the SNOP patient having a large lamina
papyracea defect without any associated malignancy.15 The
third article compared three types of sinonasal papillomas
including nine SNOP cases.9 None of them had any associa-
tion with malignancy or dysplasia. In addition to the
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previous three articles, there are more reports in the litera-
ture concerning the association between SNOP and malig-
nancy. Hyams reported one synchronous squamous cell
carcinoma (10%) in a series of 10 SNOP cases.4 Barnes and
Bedetti reported one synchronous mucoepidemoid carci-
noma among six SNOP cases.2 Karligkiotis et al found one
synchronous squamous cell carcinoma among 33 SNOP
cases.7 Kapadia et al reported nine cases of carcinoma ex
SNOP from two major institutions.20 In eight cases, the
malignancy was synchronous and metachronous in one.
There were six squamous cell carcinomas, two mucoepider-
moid carcinomas, and one undifferentiated carcinoma.
Based on the literature ﬁndings mentioned above, it seems
that nearly all malignancies associated with SNOP are
synchronous in nature and metachronous malignancies are
rare. This conclusion might be an important addition to
patient counseling.
Limitations of the Study
The present study has some limitations. Due to the
rarity of oncocytic papilloma, the series had to be col-
lected retrospectively and the size of the material still
remained small. The retrospective nature of the study
had a negative impact on the quantity and quality of the
information and this should be taken into account when
interpreting the results. Prospective study setting with
systematic data collection would naturally enable more
reliable information. Although some clear differences
were found, the small sample size inﬂuenced the statisti-
cal signiﬁcance of the present results. Furthermore, the
null hypothesis of no difference between the groups can-
not be excluded. Therefore, the results should be con-
ﬁrmed with a larger sample size in a multicenter setting.
CONCLUSION
We conclude that recurrences are common after pri-
mary surgery for SNOP. History of smoking, purulent
rhinosinusitis during the primary surgery, and tumor site
outside the nasal cavity, that is, in the paranasal sinuses
were parameters contributing to an increased tendency
for risk of recurrences, but however, these ﬁndings did
not reach statistical signiﬁcance. According to the present
report and to earlier literature, metachronous malignan-
cies are rare in the patient population with SNOP.
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